Cosdosiran is an siRNA targeting caspase-2, an enzyme involved in apoptosis. It was developed for the treatment of eye diseases—nonarteritic anterior ischaemic optic neuropathy (NAION) and primary angle closure glaucoma.
* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
Catalog
BRP-02771
Synonyms
QPI-1007; RNA, (A-Gm-G-Am-G-Um-U-Cm-C-A-Cm-A-Um-U-Cm-U-Gm-G-Cm), complex with RNA ([1'-de(6-amino-9H-purin-9-yl)]dA-(5'→5')-G-C-C-A-G-A-A-U-G-U-G-G-A-A-C-U-C-β-L-dC-U) (1:1)